Efficacy and side effects of Blacksoap® as adjuvant therapy of scabies: a randomized control trial
BACKGROUND Blacksoap® is recognized as adjuvant therapy for scabies, but there has been no significant study on its effectiveness. This study aimed to compare the efficacy and safety between Blacksoap® and placebo on standard treatment for pruritus visual analog scale (VAS) and transepidermal water loss (TEWL) scores before and after receiving therapy.
METHODS This single-blind randomized controlled trial was held in a boarding school in West Java in 2018. Subjects were recruited consecutively by random cluster sampling. Both groups received standard permethrin 5% cream therapy. The intervention group (n = 37) obtained Blacksoap®, while the control (n = 41) received baby soap. During the initial assessment, pruritus VAS and TEWL scores were taken. The cure rate, scores of pruritus VAS and TEWL, as well as side effects were assessed and compared during the first and fourth weeks. Data were analyzed using SPSS software version 20 (IBM Corp., USA) by a third party, mostly using non-parametric tests.
RESULTS The cure rate of the intervention group was lower than the control in the first week with 75% versus 81% but higher in the fourth week with 97% versus 92%. There was no significant difference in the scores of pruritus VAS and TEWL, as well as side effects between the two groups.
CONCLUSIONS The efficacy and safety of scabies treatment were similar between Blacksoap® and placebo adjunctive to standard treatment. Blacksoap®, on top of standard scabies treatment, might benefit patients by providing a higher cure rate in 4 weeks without any considerable adverse effects.
Boediardja SA, Handoko RP. Scabies. In: Menaldi SL, Bramono KS, Indriatmi W, editors. Dermatology and venereology. 7th ed. Jakarta: Faculty of Medicine Universitas Indonesia Publisher; 2017. p. 137-40. Indonesian.
Shimose L, Munoz-Price LS. Diagnosis, prevention, and treatment of scabies. Curr Infect Dis Rep. 2013;15(5):426-31. https://doi.org/10.1007/s11908-013-0354-0
Mila-Kierzenkowska C, Woźniak A, Krzyżyńska-Malinowska E, Kałużna L, Wesołowski R, Poćwiardowski W, et al. Comparative efficacy of topical pertmehrin, crotamiton and sulfur ointment in treatment of scabies. J Arthropod Borne Dis. 2017;11(1):1-9.
Romani L, Steer AC, Whitfeld MJ, Kaldor JM. Prevalence of scabies and impetigo worldwide: a systematic review. Lancet Infect Dis. 2015;15(8):960-7. https://doi.org/10.1016/S1473-3099(15)00132-2
Shin K, Jin H, You HS, Kim JM, Shim WH, Kim GW, et al. Clinical characteristics of pruritus in scabies. Indian J Dermatol Venereol Leprol. 2017;83(4):492-3. https://doi.org/10.4103/ijdvl.IJDVL_1136_16
Widaty S, Soebono H, Nilasari H, Listiawan MY, Siswati AS, Triwahyudi D, et al, editors. [Standard clinical practices for dermatovenereologist in Indonesia]. Jakarta: Indonesian Society of Dermatology and Venereology; 2017. p. 131-2. Indonesian.
Blacksoap [package insert]. Bogor: PT. Galenium Pharmasia Laboratories. 2017.
Wolf R, Parish LC. Effect of soaps and detergents on epidermal barrier function. Clin Dermatol. 2012;30(3):297-300. https://doi.org/10.1016/j.clindermatol.2011.08.021
Pillai S, Maco M, Oresajo C, Baalbaki N. Epidermal barrier. In: Draelos ZD, editor. Cosmetic dermatology: products and procedures. 2nd ed. West Sussex: John Wiley & Sons; 2016. p. 10. https://doi.org/10.1002/9781118655566.ch1
Voegeli D. The effect of washing and drying practices on skin barrier function. J Wound Ostomy Continence Nurs. 2008;35(1):84-90. https://doi.org/10.1097/01.WON.0000308623.68582.d7
Centers for Disease Control and Prevention (CDC). Scabies. [Internet]. US Department of Health & Human Services. 2019; [updated 2019, cited 2020 Nov 23]. Available from: https://www.cdc.gov/parasites/scabies/health_professionals/meds.html#:~:text=Permethrin%20kills%20the%20scabies%20mite,can%20be%20treated%20with%20permethrin.
Ranjkesh MR, Naghili B, Goldust M, Rezaee E. The efficacy of permethrin 5% vs. oral ivermectin for the treatment of scabies. Ann Parasitol. 2013;59(4):189-94.
Chhaiya SB, Patel VJ, Dave JN, Mehta DS, Shah HA. Comparative efficacy and safety of topical permethrin, topical ivermectin, and oral ivermectin in patients of uncomplicated scabies. Indian J Dermatol Venereol Leprol. 2012;78(5):605-10. https://doi.org/10.4103/0378-6323.100571
Hashimoto K, Fujiwara K, Punwaney J, DiGregorio F, Bostrom P, el-Hoshy K, et al. Post-scabetic nodules: a lymphohistiocytic reaction rich in indeterminate cells. J Dermatol. 2000;27(3):181-94. https://doi.org/10.1111/j.1346-8138.2000.tb02148.x
Kajs TM, Gartstein V. Review of the instrumental assessment of skin: effects of cleansing products. J Soc Cosmet Chem. 1991;42:249-71.
Packham H. A new approach to skin health assessment [Internet]. [cited 2018 Sep 1]. Available from: www.aiha.org/aihce04/handouts/po114packham.pdf.
Salavastru CM, Chosidow O, Boffa MJ, Janier M, Tiplica GS. European guideline for the management of scabies. J Eur Acad Dermatol Venereol. 2017;31(8):1248-53. https://doi.org/10.1111/jdv.14351
Copyright (c) 2022 Lidwina Anissa, Wresti Indriatmi, Larisa Paramitha Wibawa, Sandra Widaty
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish with Medical Journal of Indonesia agree to the following terms:
- Authors retain copyright and grant Medical Journal of Indonesia right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial License that allows others to remix, adapt, build upon the work non-commercially with an acknowledgment of the work’s authorship and initial publication in Medical Journal of Indonesia.
- Authors are permitted to copy and redistribute the journal's published version of the work non-commercially (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in Medical Journal of Indonesia.